HRA® offers compensation of $800 to advanced practice providers for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Please note: this is a non-CME, independently produced program. All content is developed by the HCPLive® team.

OVERVIEW

HCPLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with health care professionals (HCPs) to present data, medical advances, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science, feedback on case scenarios, as well as other information which impact the clinical decision making of local HCPs.

These forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care.

LEARNING OBJECTIVES

Assess current drivers of treatment escalation in asthma and COPD, including symptom burden, exacerbation patterns, biomarker thresholds, and guideline recommendations.
Identify real-world barriers to timely use of biologic therapies in asthma and COPD and discuss strategies to create greater urgency in care.
Apply clinical trial data and emerging evidence to identify patient populations who might benefit from biologic therapies in asthma and COPD.